DBT logo

Ben Tre Pharmaceutical Joint Stock Company Stock Price

HOSE:DBT Community·₫237.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

DBT Share Price Performance

₫10,800.00
-87.85 (-0.81%)
₫10,800.00
-87.85 (-0.81%)
Price ₫10,800.00

DBT Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Slight risk with imperfect balance sheet.

4 Risks
0 Rewards

Ben Tre Pharmaceutical Joint Stock Company Key Details

₫860.4b

Revenue

₫521.9b

Cost of Revenue

₫338.5b

Gross Profit

₫324.4b

Other Expenses

₫14.0b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
638.88
39.34%
1.63%
185.5%
View Full Analysis

About DBT

Founded
1963
Employees
684
CEO
Pham Trieu
WebsiteView website
www.bepharco.com

Ben Tre Pharmaceutical Joint Stock Company manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally. The company offers drugs in injectable, infusion, pill, and lotion forms. The company provides products covering various therapeutic areas, including central nervous system, respiratory system, endocrinology, obstetrics and gynecology, anti-allergic, cardiovascular, antibiotics, anti-fungal, anti-viral, musculoskeletal, vitamins and minerals, digestive, hepatobiliary and urinary, pain relief, fever reducer, anti-inflammatory, on-site impact, and diabetics, as well as herbal medicines. It offers supplements and medical devices. The company was founded in 1963 and is headquartered in Ben Tre, Vietnam.

Recent DBT News & Updates

Recent updates

No updates

Ben Tre Pharmaceutical Joint Stock Company Competitors